Alessandra Marengoni

researcher

Alessandra Marengoni is …
instance of (P31):
humanQ5

External links are
P1960Google Scholar author IDTwE02n0AAAAJ
P10070IRIS UNIPG author ID35530
P6634LinkedIn personal profile IDalessandra-marengoni-b549b838
P11718OPENBS author ID01281
P496ORCID iD0000-0002-4851-1825

P69educated atKarolinska InstitutetQ219564
P108employerUniversity of BresciaQ1781263
P735given nameAlessandraQ4960889
AlessandraQ4960889
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q40186889A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study
Q39021867Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database
Q40461267Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency.
Q58419014Adverse Clinical Events and Mortality During Hospitalization and 3 Months After Discharge in Cognitively Impaired Elderly Patients
Q39076795Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization.
Q44881260Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study
Q45764426Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study
Q57285620Atrial fibrillation, antithrombotic treatment, and cognitive aging: A population-based study
Q51035799C-reactive protein, lipoprotein (a) and cystatin C levels increase with multimorbidity in older persons.
Q40235798Chronic diseases and geriatric syndromes: The different weight of comorbidity
Q93152042Co-occurrence of cognitive impairment and physical frailty, and incidence of dementia: Systematic review and meta-analysis
Q40871028Coexisting chronic conditions in the older population: Variation by health indicators
Q39059297Combining Gait Speed and Recall Memory to Predict Survival in Late Life: Population-Based Study
Q33638042Comorbidity and progression of late onset Alzheimer's disease: A systematic review
Q92552481Drug Prescription and Delirium in Older Inpatients: Results From the Nationwide Multicenter Italian Delirium Day 2015-2016
Q44670806Drug-drug interactions in a cohort of hospitalized elderly patients.
Q40287658Effect of Chronic Diseases and Multimorbidity on Survival and Functioning in Elderly Adults
Q30847108Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).
Q64280771EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research
Q40736256Frailty and Drug Use.
Q33945995Incidence and predictors of multimorbidity in the elderly: a population-based longitudinal study
Q26781959Interventional tools to improve medication adherence: review of literature
Q58376526Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation
Q104476819Multimorbidity Patterns and Unplanned Hospitalisation in a Cohort of Older Adults
Q57792412Multimorbidity and functional impairment: bidirectional interplay, synergistic effects and common pathways
Q47670424Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS).
Q92481329Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study
Q92270166Patterns of Multimorbidity in a Population-Based Cohort of Older People: Sociodemographic, Lifestyle, Clinical, and Functional Differences
Q58376542Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study
Q92169533Predicting Cognitive and Functional Trajectories in People With Late-Onset Dementia: 2 Population-Based Studies
Q44337647Prescription drug use among older adults in Italy: a country-wide perspective.
Q44452297Prognostic value of estimated glomerular filtration rate in hospitalized elderly patients
Q43513337Prophylaxis of venous thromboembolism in elderly patients with multimorbidity
Q50055255Rapidly developing multimorbidity and disability in older adults: does social background matter?
Q58376533Risk factors for hospital readmission of elderly patients
Q36064517Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification
Q47986401Social networks and health status in the elderly: the 'ANZIANI IN-RETE' population-based study
Q37214080Socioeconomic status during lifetime and cognitive impairment no-dementia in late life: the population-based aging in the Chianti Area (InCHIANTI) Study
Q47625353The Effect of a 2-Year Intervention Consisting of Diet, Physical Exercise, Cognitive Training, and Monitoring of Vascular Risk on Chronic Morbidity-the FINGER Randomized Controlled Trial
Q57149761The Relationship between Anaemia and Frailty: A Systematic Review and Meta-Analysis of Observational Studies
Q39434611Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study
Q51765490Trajectories of functional decline in older adults with neuropsychiatric and cardiovascular multimorbidity: A Swedish cohort study.
Q53082927Understanding adverse drug reactions in older adults through drug-drug interactions.
Q92405222Walking Speed Drives the Prognosis of Older Adults with Cardiovascular and Neuropsychiatric Multimorbidity